Report #2831543

Received Mar 14, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
COVID19	COVID19 (COVID19 (JANSSEN))	JANSSEN	UNK	—	—

Symptoms (1)

Adverse drug reaction

Symptom narrative

mild symptoms; This spontaneous report received from a patient by a business partner (Pfizer Inc.) on 25-Feb-2025 was received by Johnson and Johnson Innovative Medicine on 25-Feb-2025 and concerned multiple unspecified age and sex patients. The patients height and weight were not reported. Age at time of vaccination was unknown. No past medical history, concurrent conditions or pre-existing medical conditions were reported. The patients received janssen covid-19 vaccine (suspension for injection, intramuscular, batch number not reported) dose, frequency and therapy dates not reported, additional dosage information included: Dose Series: 1, for covid-19 prophylaxis. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patients experienced mild symptoms. Dose Series: 1 The action taken with janssen covid-19 vaccine was not applicable. The outcome of mild symptoms was not reported. This report was non-serious.